Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Cancers 2011, 3(3), 3661-3675; doi:10.3390/cancers3033661
Review

Natural Killer T Cells Subsets in Cancer, Functional Defects in Prostate Cancer and Implications for Immunotherapy

*  and
Received: 11 July 2011; in revised form: 1 September 2011 / Accepted: 13 September 2011 / Published: 20 September 2011
(This article belongs to the Special Issue Prostate Cancer)
View Full-Text   |   Download PDF [158 KB, uploaded 20 September 2011]
Abstract: Natural killer T cells are T lymphocytes with unique activation and effector properties. The majority of NKT cells, termed type-I or iNKT cells, recognize lipid antigens presented on MHC-like CD1d molecules. Type-I NKT cells have the capacity to rapidly secrete various cytokines upon activation, thereby regulate immune responses exerts dominant anti-tumor and anti-microbial effector functions. Specific activation of type-I NKT cells in mouse models boosts immunity and prevents metastasis, which has led to a number of phase I-II clinical trials. Since the discovery of NKT cells other subsets with different specificities and effector functions have been described. This article briefly reviews the physiological functions of NKT cell subsets, their implications in cancer and the attempts that have been made to employ NKT cells for immune therapy of cancer.
Keywords: NKT cell; prostate cancer; immunotherapy NKT cell; prostate cancer; immunotherapy
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Nowak, M.; Schmidt-Wolf, I.G. Natural Killer T Cells Subsets in Cancer, Functional Defects in Prostate Cancer and Implications for Immunotherapy. Cancers 2011, 3, 3661-3675.

AMA Style

Nowak M, Schmidt-Wolf IG. Natural Killer T Cells Subsets in Cancer, Functional Defects in Prostate Cancer and Implications for Immunotherapy. Cancers. 2011; 3(3):3661-3675.

Chicago/Turabian Style

Nowak, Michael; Schmidt-Wolf, Ingo G.H. 2011. "Natural Killer T Cells Subsets in Cancer, Functional Defects in Prostate Cancer and Implications for Immunotherapy." Cancers 3, no. 3: 3661-3675.



Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert